|
|
Volumn 53, Issue SUPPL. 3, 2004, Pages
|
|
Impact of treatment on islet function in type 2 diabetes
a
|
|
Author keywords
[No Author keywords available]
|
|
Indexed keywords
CARBUTAMIDE;
DIPEPTIDYL PEPTIDASE IV;
GLUCAGON LIKE PEPTIDE 1;
HYDROXYMETHYLGLUTARYL COENZYME A REDUCTASE KINASE;
INSULIN;
INWARDLY RECTIFYING POTASSIUM CHANNEL SUBUNIT KIR6.2;
LIVER X RECEPTOR;
PEROXISOME PROLIFERATOR ACTIVATED RECEPTOR GAMMA;
POTASSIUM CHANNEL;
PRAMLINTIDE;
PROINSULIN;
SOMATOSTATIN;
STEROL REGULATORY ELEMENT BINDING PROTEIN;
SULFONYLUREA DERIVATIVE;
CALCIUM MOBILIZATION;
CELL STIMULATION;
CONFERENCE PAPER;
DRUG EFFECT;
GLUCOSE BLOOD LEVEL;
GLUCOSE HOMEOSTASIS;
GLUCOSE TOLERANCE TEST;
HEART MUSCLE CELL;
HEART REPOLARIZATION;
HIGH RISK POPULATION;
HUMAN;
INSULIN LIKE ACTIVITY;
INSULIN RELEASE;
INSULIN RESISTANCE;
INSULIN RESPONSE;
NON INSULIN DEPENDENT DIABETES MELLITUS;
PANCREAS ISLET CELL FUNCTION;
PATHOPHYSIOLOGY;
PRIORITY JOURNAL;
RISK BENEFIT ANALYSIS;
TARGET CELL;
DIABETES MELLITUS, TYPE 2;
HUMANS;
HYPOGLYCEMIC AGENTS;
INSULIN;
ISLETS OF LANGERHANS;
|
|
EID: 9444236149
PISSN: 00121797
EISSN: None
Source Type: Journal
DOI: 10.2337/diabetes.53.suppl_3.S1 Document Type: Conference Paper |
|
Times cited : (2)
|
|
References (9)
|
